Effect of topical alendronate on root resorption of dried replanted dog teeth.
Alendronate (ALN) is a third generation bisphosphonate with demonstrated osteoclast inhibitory activity that may slow down the resorptive process after severe traumatic injuries. Eighty-two premolar roots of five mongrel dogs were endodontically treated and restored, extracted and treated as follows: 70 roots were bench dried for either 40 or 60 min. Thirty-eight of these roots were then soaked for 5 min in a 1 mM solution of ALN in Hanks' Balanced Salt Solution (HBSS) and replanted. Thirty-two roots were soaked for 5 min in HBSS and replanted. In the remaining 12 roots which were not exposed to the bench drying procedure, a 0.5 mM deep lingual mid-root cemental defect was made. Six of these roots were soaked in a 1 mM solution of ALN in HBSS for 5 min and replanted. The other six roots were soaked for 5 min in HBSS and replanted. Historical negative and positive controls were used from similarly treated teeth in our previous studies. After 4 months the dogs were killed and the roots prepared for histological evaluation. Five-microm-thick cross-sections of the root and surrounding tissue taken every 70 microm were evaluated for healing according to the criteria of Andreasen. In the 12 roots with cemental defects, healing with cementum of the damaged root surface was evaluated. In addition, residual root mass was also measured to determine the extent of root structure loss for each soaking method. Cemental healing took place in all 12 artificially damaged roots, indicating that these soaking media did not inhibit cementogenesis. The alendronate-soaked roots had statistically significantly more healing than the roots soaked in HBSS without alendronate. This improvement in healing was seen in all dogs except one and in all teeth except the first premolar. Soaking in alendronate also resulted in significantly less loss in root mass due to resorption compared to those teeth soaked in HBSS without alendronate.
Levin
L
L
Department of Endodontics, School of Dentistry, University of North Carolina at Chapel Hill, 27599-7450, USA. llevin@dentistry.unc.edu
Bryson
E C
EC
Caplan
D
D
Trope
M
M
D000287:Administration, Topical; D019386:Alendronate / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D000844:Ankylosis / Q000209:etiology / Q000473:pathology; D001641:Bicuspid; D016009:Chi-Square Distribution; D003739:Dental Cementum / Q000293:injuries / Q000473:pathology; D003890:Desiccation; D004195:Disease Models, Animal; D004285:Dogs; D007552:Isotonic Solutions / Q000627:therapeutic use; D010010:Osteoclasts / Q000187:drug effects; D012390:Root Canal Therapy; D012391:Root Resorption / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D013223:Statistics as Topic; D013997:Time Factors; D014021:Tissue Preservation; D014084:Tooth Avulsion / Q000628:therapy; D014090:Tooth Replantation / Q000009:adverse effects; D014092:Tooth Root / Q000293:injuries / Q000473:pathology; D014945:Wound Healing
C072670:Hanks Balanced Salt Solution; D007552:Isotonic Solutions; D019386:Alendronate